Pacific Global Investment Management CO Merck & Co., Inc. Transaction History

Pacific Global Investment Management CO

$529 Million
Q3 2024

A detailed history of Pacific Global Investment Management CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pacific Global Investment Management CO holds 15,493 shares of MRK stock, worth $1.55 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

15,493

Previous 15,891 2.5%

Holding current value

$1.55 Million

Previous $1.97 Million 10.57%

% of portfolio

0.33%

Previous 0.39%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$111.15 - $128.97 $44,237 - $51,330	-398 Reduced 2.5%	15,493 $1.76 Million
Q2 2024 Aug 09, 2024	SELL	$123.8 - $132.96 $66,852 - $71,798	-540 Reduced 3.29%	15,891 $1.97 Million
Q1 2024 May 10, 2024	SELL	$113.24 - $131.95 $186,053 - $216,793	-1,643 Reduced 9.09%	16,431 $2.17 Million
Q4 2023 Feb 08, 2024	BUY	$100.18 - $109.02 $5,209 - $5,669	52 Added 0.29%	18,074 $1.97 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $66,814 - $74,200	-649 Reduced 3.48%	18,022 $1.86 Million
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $111,108 - $121,102	-1,023 Reduced 5.19%	18,671 $2.15 Million
Q1 2023 Apr 28, 2023	SELL	$102.94 - $114.86 $80,087 - $89,361	-778 Reduced 3.8%	19,694 $2.1 Million
Q4 2022 Feb 14, 2023	SELL	$87.44 - $112.11 $17,925 - $22,982	-205 Reduced 0.99%	20,472 $2.27 Million
Q3 2022 Nov 01, 2022	BUY	$84.53 - $94.96 $30,177 - $33,900	357 Added 1.76%	20,677 $1.78 Million
Q2 2022 Aug 05, 2022	SELL	$83.49 - $94.64 $10,269 - $11,640	-123 Reduced 0.6%	20,320 $1.85 Million
Q1 2022 Apr 25, 2022	SELL	$73.51 - $82.4 $12,643 - $14,172	-172 Reduced 0.83%	20,443 $1.68 Million
Q4 2021 Feb 03, 2022	SELL	$72.28 - $90.54 $120,924 - $151,473	-1,673 Reduced 7.51%	20,615 $1.58 Million
Q3 2021 Nov 04, 2021	BUY	$71.68 - $78.83 $13,977 - $15,371	195 Added 0.88%	22,288 $1.67 Million
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $38,178 - $42,229	-543 Reduced 2.4%	22,093 $1.72 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $157,000 - $184,930	2,280 Added 11.2%	22,636 $1.75 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $1.46 Million - $1.62 Million	20,356 New	20,356 $1.67 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $70,179 - $79,549	959 Added 4.87%	20,638 $1.71 Million
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $1.37 Million - $1.55 Million	-19,405 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$63.36 - $87.82 $55,059 - $76,315	-869 Reduced 4.29%	19,405 $1.49 Million
Q4 2019 Feb 14, 2020	SELL	$77.58 - $87.54 $77 - $87	-1 Reduced -0.0%	20,274 $1.84 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $15,672 - $17,083	206 Added 1.03%	20,275 $1.71 Million
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $37,992 - $44,384	-544 Reduced 2.64%	20,069 $1.68 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $1,461 - $1,666	-21 Reduced 0.1%	20,613 $1.71 Million
Q4 2018 Feb 14, 2019	SELL	$65.24 - $75.71 $18,984 - $22,031	-291 Reduced 1.39%	20,634 $1.58 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $10,845 - $12,753	-188 Reduced 0.89%	20,925 $1.48 Million
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $25,669 - $30,158	-505 Reduced 2.34%	21,113 $1.28 Million
Q1 2018 May 15, 2018	SELL	$50.96 - $59.23 $4,790 - $5,567	-94 Reduced 0.43%	21,618 $1.18 Million
Q4 2017 Feb 14, 2018	SELL	$51.62 - $61.64 $158,834 - $189,666	-3,077 Reduced 12.41%	21,712 $1.22 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $182,170 - $196,018	3,105 Added 14.32%	24,789 $1.59 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,684	21,684 $1.39 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Global Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Global Investment Management CO with notifications on news.

Account

Pacific Global Investment Management CO Merck & Co., Inc. Transaction History